Can we omit aspirin when anticoagulated patients undergo PCI?

Dr Samuel Goldhaber


March 01, 2013

This feature requires the newest version of Flash. You can download it here.

The WOEST study—which was presented at ESC 2012 and has been published in the Lancet—provides valuable clinical-trial data to the debate on double vs triple therapy in anticoagulated patients undergoing PCI. It's a thought-provoking study. Is it time to act on the results?

See also:

WOEST: Drop aspirin in stent patients on oral anticoagulants

Dewilde WJM, Verheugt FWA, Kelder JC, et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: An open-label, randomised, controlled trial. Lancet 2013; epub ahead of print. Abstract.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.